Nuclear Imaging Equipment Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Nuclear Imaging Equipment Pipeline Market Report Overview

Nuclear imaging equipment makes use of radioactive substances that are inserted into the body orally or intravenously. Nuclear Imaging systems capture the radiations emitted by radiopharmaceuticals to create images of the structures and activities inside the human body. These images enable physicians to look inside a human body to help determine the cause of an illness or injury and provide an accurate diagnosis.

The nuclear imaging equipment pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials.

Key Categories ·        Positron Emission Tomography (PET) Systems

·        Positron Emission Tomography/Computed Tomography (PET/CT) Systems

·        Positron Emission Tomography/Magnetic Resonance Imaging (PET/MRI) Systems

·        Single Photon Emission Computed Tomography/Computed Tomography (SPECT/CT) Systems

·        Single Photon Emission Computed Tomography (SPECT) Systems

Key Territories ·        United States

·        Europe

·        Canada

·        China

·        Australia

Key Regulatory Paths ·        510(k)

·        CE

·        MDL

·        NMPA

Leading Companies ·        Brain Biosciences Inc

·        Canon Medical Systems USA Inc

·        Cubresa Inc

·        ELECTRON Ltd.

·        Emory University

Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Nuclear Imaging Equipment Pipeline Market Segmentation by Categories

A few of the key categories associated with the nuclear imaging equipment pipeline market are positron emission tomography (PET) systems, positron emission tomography/computed tomography (PET/CT) systems, positron emission tomography/magnetic resonance imaging (PET/MRI) systems, single photon emission computed tomography/computed tomography (SPECT/CT) systems, and single photon emission computed tomography (SPECT) systems among others. As of October 2024, positron emission tomography (PET) systems accounted as the leading category.

Nuclear Imaging Equipment Pipeline Market Analysis by Categories, 2024 (%)

Nuclear Imaging Equipment Pipeline Market Analysis by Categories, 2024 (%)

Buy the Full Report for More Category Insights into the Nuclear Imaging Equipment Pipeline Market

Download a Free Report Sample

Nuclear Imaging Equipment Pipeline Market Segmentation by Territories

A few of the key territories associated with the nuclear imaging equipment pipeline market are the United States, Europe, Canada, China, and Australia. As of October 2024, the US had the highest number of nuclear imaging equipment pipeline products.

Nuclear Imaging Equipment Pipeline Market Analysis by Territories, 2024 (%)

Nuclear Imaging Equipment Pipeline Market Analysis by Territories, 2024 (%)

Buy the Full Report for More Territory Insights into the Nuclear Imaging Equipment Pipeline Market

Download a Free Report Sample

Nuclear Imaging Equipment Pipeline Market Segmentation by Regulatory Paths

A few of the key regulatory paths in the nuclear imaging equipment pipeline products market are 510(k), CE, MDL, and NMPA. As of October 2024, 510(k) was the most followed pathway for pipeline products in the nuclear imaging equipment market.

Nuclear Imaging Equipment Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Nuclear Imaging Equipment Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Buy the Full Report for More Regulatory Path Insights into the Nuclear Imaging Equipment Pipeline Market

Download a Free Report Sample

Nuclear Imaging Equipment Pipeline Market – Competitive Landscape

A few of the key companies associated with the nuclear imaging equipment pipeline market are Brain Biosciences Inc, Canon Medical Systems USA Inc, Cubresa Inc, ELECTRON Ltd., and Emory University among others.

Canon Medical Systems USA Inc: Canon Medical Systems USA Inc (CMSU), a subsidiary of Canon Medical Systems Corp, is a medical equipment manufacturing company. The company’s products include angiography systems, computed tomography (CT) systems, molecular imaging system, magnetic resonance imaging (MRI) systems, ultrasound systems, x-ray systems, healthcare information technology, eye care products, among others. It offers service agreements and cybersecurity protection services.

Cubresa Inc: Cubresa, Inc. is a provider of handheld and portable gamma camera systems intended for breast radiology, surgical oncology for lymphatic mapping and sentinel node identification, and image guided radiotherapy.

Nuclear Imaging Equipment Pipeline Market Analysis by Companies, As of October 2024
Nuclear Imaging Equipment Pipeline Market Analysis by Companies, As of October 2024Buy the Full Report for More Company Insights into the Nuclear Imaging Equipment Pipeline Market
Download a Free Report Sample

Segments Covered in the Report

Nuclear Imaging Equipment Pipeline Market Territories Outlook (2024)

  • United States
  • Europe
  • Canada
  • China
  • Australia

Nuclear Imaging Equipment Pipeline Market Regulatory Paths Outlook (2024)

  • 510(k)
  • CE
  • MDL
  • NMPA

Scope

The report provides:

  • Extensive coverage of the nuclear imaging equipment under development.
  • The report reviews details of major pipeline products which include, product description, licensing and collaboration details, and other developmental activities.
  • The report reviews the major players involved in the development of nuclear imaging equipment and lists all their pipeline projects.
  • Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.
  • The report provides key clinical trial data of ongoing trials specific to pipeline products.
  • Recent developments in the segment/industry.

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies.
  • Identify emerging players with  potentially strong product portfolios and create effective counter strategies to gain a competitive advantage.
  • Identify and understand important and diverse types of nuclear imaging equipment under development.
  • Develop market-entry and market-expansion strategies.
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.
  • In-depth analysis of the product’s current stage of development, territory, and estimated launch date.

Brain Biosciences Inc
Canon Medical Systems USA Inc
Cubresa Inc
ELECTRON Ltd.
Emory University
Endocyte Inc (Inactive)
EXINI Diagnostics AB
FMI Medical Systems Inc
General De Equipment for Medical Imaging SA
General Electric Global Research Center
Jagiellonian University
King's College London
Massachusetts General Hospital
Memorial Sloan Kettering Cancer Center
Molecular Dynamics
MultiFunctional Imaging LLC
Nalu Scientific LLC
Navidea Biopharmaceuticals Inc
Neusoft Medical Systems Co Ltd
Noras MRI products GmbH
Petcoil Inc
Philips Healthcare Informatics Inc
Positron Corporation
Pulmoscience Inc
QUIBIM SL
Radialis Medical Inc
Ruhr-University Bochum
Senotrac Biotechnology LLC
Shanghai United Imaging Healthcare Co Ltd
Shanghai United Imaging Intelligent Medical Technology Co Ltd
Siemens Healthineers AG
Siemens Medical Solutions USA Inc
Stanford University
Symetrica Security Ltd
SynchroPET
Terapet SA
University of Arizona
University of California Davis
University of California Los Angeles
University of California Santa Cruz
University of the Witwatersrand
University of Washington
West Virginia University
Zecotek Photonics Inc
ZumaTek, Inc.

Table of Contents

|1 Table of Contents

|1.1 List of Tables

|1.2 List of Figures

2 Introduction

2.1 Nuclear Imaging Equipment Overview

3 Products under Development

3.1 Nuclear Imaging Equipment – Pipeline Products by Stage of Development

3.2 Nuclear Imaging Equipment – Pipeline Products by Segment

3.3 Nuclear Imaging Equipment – Pipeline Products by Territory

3.4 Nuclear Imaging Equipment – Pipeline Products by Regulatory Path

3.5 Nuclear Imaging Equipment – Pipeline Products by Estimated Approval Date

3.6 Nuclear Imaging Equipment – Ongoing Clinical Trials

4 Nuclear Imaging Equipment – Pipeline Products under Development by Companies

4.1 Nuclear Imaging Equipment Companies – Pipeline Products by Stage of Development

4.2 Nuclear Imaging Equipment – Pipeline Products by Stage of Development

5 Nuclear Imaging Equipment Companies and Product Overview

5.1 Brain Biosciences Inc Company Overview

5.1.1 Brain Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview

5.2 Canon Medical Systems USA Inc Company Overview

5.2.1 Canon Medical Systems USA Inc Pipeline Products & Ongoing Clinical Trials Overview

5.3 Cubresa Inc Company Overview

5.3.1 Cubresa Inc Pipeline Products & Ongoing Clinical Trials Overview

5.4 ELECTRON Ltd. Company Overview

5.4.1 ELECTRON Ltd. Pipeline Products & Ongoing Clinical Trials Overview

5.5 Emory University Company Overview

5.5.1 Emory University Pipeline Products & Ongoing Clinical Trials Overview

5.6 Endocyte Inc (Inactive) Company Overview

5.6.1 Endocyte Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

5.7 EXINI Diagnostics AB Company Overview

5.7.1 EXINI Diagnostics AB Pipeline Products & Ongoing Clinical Trials Overview

5.8 FMI Medical Systems Inc Company Overview

5.8.1 FMI Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview

5.9 General De Equipment for Medical Imaging SA Company Overview

5.9.1 General De Equipment for Medical Imaging SA Pipeline Products & Ongoing Clinical Trials Overview

5.10 General Electric Global Research Center Company Overview

5.10.1 General Electric Global Research Center Pipeline Products & Ongoing Clinical Trials Overview

5.11 Jagiellonian University Company Overview

5.11.1 Jagiellonian University Pipeline Products & Ongoing Clinical Trials Overview

5.12 King’s College London Company Overview

5.12.1 King’s College London Pipeline Products & Ongoing Clinical Trials Overview

5.13 Massachusetts General Hospital Company Overview

5.13.1 Massachusetts General Hospital Pipeline Products & Ongoing Clinical Trials Overview

5.14 Memorial Sloan Kettering Cancer Center Company Overview

5.14.1 Memorial Sloan Kettering Cancer Center Pipeline Products & Ongoing Clinical Trials Overview

5.15 Molecular Dynamics Company Overview

5.15.1 Molecular Dynamics Pipeline Products & Ongoing Clinical Trials Overview

5.16 MultiFunctional Imaging LLC Company Overview

5.16.1 MultiFunctional Imaging LLC Pipeline Products & Ongoing Clinical Trials Overview

5.17 Nalu Scientific LLC Company Overview

5.17.1 Nalu Scientific LLC Pipeline Products & Ongoing Clinical Trials Overview

5.18 Navidea Biopharmaceuticals Inc Company Overview

5.18.1 Navidea Biopharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview

5.19 Neusoft Medical Systems Co Ltd Company Overview

5.19.1 Neusoft Medical Systems Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.20 Noras MRI products GmbH Company Overview

5.20.1 Noras MRI products GmbH Pipeline Products & Ongoing Clinical Trials Overview

5.21 Petcoil Inc Company Overview

5.21.1 Petcoil Inc Pipeline Products & Ongoing Clinical Trials Overview

5.22 Philips Healthcare Informatics Inc Company Overview

5.22.1 Philips Healthcare Informatics Inc Pipeline Products & Ongoing Clinical Trials Overview

5.23 Positron Corporation Company Overview

5.23.1 Positron Corporation Pipeline Products & Ongoing Clinical Trials Overview

5.24 Pulmoscience Inc Company Overview

5.24.1 Pulmoscience Inc Pipeline Products & Ongoing Clinical Trials Overview

5.25 QUIBIM SL Company Overview

5.25.1 QUIBIM SL Pipeline Products & Ongoing Clinical Trials Overview

5.26 Radialis Medical Inc Company Overview

5.26.1 Radialis Medical Inc Pipeline Products & Ongoing Clinical Trials Overview

5.27 Ruhr-University Bochum Company Overview

5.27.1 Ruhr-University Bochum Pipeline Products & Ongoing Clinical Trials Overview

5.28 Senotrac Biotechnology LLC Company Overview

5.28.1 Senotrac Biotechnology LLC Pipeline Products & Ongoing Clinical Trials Overview

5.29 Shanghai United Imaging Healthcare Co Ltd Company Overview

5.29.1 Shanghai United Imaging Healthcare Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.30 Shanghai United Imaging Intelligent Medical Technology Co Ltd Company Overview

5.30.1 Shanghai United Imaging Intelligent Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.31 Siemens Healthineers AG Company Overview

5.31.1 Siemens Healthineers AG Pipeline Products & Ongoing Clinical Trials Overview

5.32 Siemens Medical Solutions USA Inc Company Overview

5.32.1 Siemens Medical Solutions USA Inc Pipeline Products & Ongoing Clinical Trials Overview

5.33 Stanford University Company Overview

5.33.1 Stanford University Pipeline Products & Ongoing Clinical Trials Overview

5.34 Symetrica Security Ltd Company Overview

5.34.1 Symetrica Security Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.35 SynchroPET Company Overview

5.35.1 SynchroPET Pipeline Products & Ongoing Clinical Trials Overview

5.36 Terapet SA Company Overview

5.36.1 Terapet SA Pipeline Products & Ongoing Clinical Trials Overview

5.37 University of Arizona Company Overview

5.37.1 University of Arizona Pipeline Products & Ongoing Clinical Trials Overview

5.38 University of California Davis Company Overview

5.38.1 University of California Davis Pipeline Products & Ongoing Clinical Trials Overview

5.39 University of California Los Angeles Company Overview

5.39.1 University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview

5.40 University of California Santa Cruz Company Overview

5.40.1 University of California Santa Cruz Pipeline Products & Ongoing Clinical Trials Overview

5.41 University of the Witwatersrand Company Overview

5.41.1 University of the Witwatersrand Pipeline Products & Ongoing Clinical Trials Overview

5.42 University of Washington Company Overview

5.42.1 University of Washington Pipeline Products & Ongoing Clinical Trials Overview

5.43 West Virginia University Company Overview

5.43.1 West Virginia University Pipeline Products & Ongoing Clinical Trials Overview

5.44 Zecotek Photonics Inc Company Overview

5.44.1 Zecotek Photonics Inc Pipeline Products & Ongoing Clinical Trials Overview

5.45 ZumaTek, Inc. Company Overview

5.45.1 ZumaTek, Inc. Pipeline Products & Ongoing Clinical Trials Overview

6 Nuclear Imaging Equipment- Recent Developments

6.1 Oct 02, 2024: CE Mark and market clearance in Europe for NeuroLF

6.2 Sep 27, 2024: Concord Medical Announces Results for H1 of 2024

6.3 Sep 10, 2024: Shanghai United Imaging Healthcare Receives Additional FDA 510(k) Clearance for uMI Panorama

6.4 Aug 19, 2024: GE HealthCare Technologies Receives Additional 510(k) Clearance For Omni Legend

6.5 Aug 05, 2024: Siemens Healthineers Receives 510(K) Clearance For InnovaMatrix FD

6.6 Aug 05, 2024: Siemens Healthineers Receives 510(K) Clearance For Symbia SPECT System

6.7 Jul 26, 2024: Positron introduces NeuSight PET-CT scanner in US and North America

6.8 Jul 17, 2024: FDA approves Positrigo’s NeuroLF brain PET system

6.9 Jul 15, 2024: United Imaging Announces First PET/CT Installation in Mexico, at National Institute of Pediatrics

6.10 Jul 15, 2024: United Imaging Announces First PET/CT Installation in Mexico, at Instituto Nacional de Pediatria

6.11 Jul 11, 2024: Hyperfine to Announce Second Quarter 2024 Financial Results on August 8, 2024

6.12 Jul 03, 2024: Navidea Biopharmaceuticals, Announces Results of Exploratory Analysis Completed on July 2, 2024

6.13 Jun 26, 2024: Positron Corporation Orders 5 NeuSight PET-CT Scanners for US Market

6.14 Jun 24, 2024: Jubilant Radiopharma Announces Investment of $50 million (USD) to Expand Positron Emission Tomography (PET) Manufacturing Network

6.15 Jun 14, 2024: Positron to sell NeuSight PET-CT scanner in North America

6.16 Jun 12, 2024: Positron Corporation Enters Agreement to Acquire FDA 510(K) for Neusight PET-CT

6.17 Jun 11, 2024: Oxford Instruments FY Pretax Profit Declines; Revenue Up

5.8%

6.18 Jun 11, 2024: Ultra-Low Dose PET Protocol Eliminates Need for CT, Uses Dose 50 Times Lower Than Current Standard

6.19 Jun 11, 2024: Oxford Instruments Announces 2024 Annual Report and Accounts

6.20 Jun 09, 2024: Siemens Healthineers Debuts Biograph Trinion Next-Generation, High-Performance PET/CT Scanner

6.21 Jun 09, 2024: Siemens Healthineers Receives FDA Clearance for High-Performance Biograph Trinion Pet/CT Scanner

6.22 Jun 08, 2024: United Imaging Prepares to Ship its 30,000th Unit Globally, a uMI Panorama GS, from Houston for U.S. Installation

6.23 Jun 07, 2024: GE Healthcare Increases Access to Precision Care Tools, Encouraging the Continued Adoption and Practice of More Personalized Medicine Around the World

6.24 Jun 07, 2024: Steve Knight Appointed Regional Sales Manager for Fire Products at Siemens

6.25 Jun 07, 2024: Non-Invasive Visualization of CAR-T and CAR-NK Cells Inside Patients

6.26 Jun 06, 2024: Shanghai United Imaging Healthcare Receives Additional 510(K) Clearance For uPMR 790 HD TOF PET/MR

6.27 Jun 05, 2024: Oxford Instruments Announces Directorate Change

6.28 Jun 05, 2024: Oxford Instruments Announces Board and Committee Changes

6.29 Jun 04, 2024: Hermes Medical Solutions and Siemens Healthineers team up to provide Dosimetry Software for Molecular Imaging Radiotherapy & Theranostics

6.30 Jun 03, 2024: QEII Health Sciences Centre First in Canada to Acquire StarGuide Hybrid SPECT/CT Nuclear Medicine Scanner Through GE HealthCare

6.31 Jun 03, 2024: Hyperfine to Host Analyst and Investor Education Webcast with Clinical and Brain Imaging Experts on June 25, 2024

6.32 May 30, 2024: GE HealthCare and Tampa General Hospital Expand Long-Term Partnership to Benefit Patients and Clinicians Across the State of Florida

6.33 May 07, 2024: Siemens Healthineers on Track to Meet Fiscal Year 2024 Targets After Second Quarter

6.34 Apr 29, 2024: Spectrum and Hermes Medical Solutions to offer vendor-neutral software

6.35 Apr 04, 2024: Nanalysis Receives Funding Supporting AI Software Development for Detection of Illicit Substances

6.36 Apr 02, 2024: Hoag First in World to Enroll Prostate Cancer Patients in Molecular Imaging & Therapy Clinical Trials

6.37 Apr 01, 2024: UC San Diego Receives $6.7M to Develop Whole-Body Inflammation Imaging

6.38 Mar 25, 2024: Siemens Healthineers introduces advanced PET/CT technology to Royal Victoria Regional Health Centre in Barrie, revolutionizing patient care for this region

6.39 Mar 21, 2024: Curasight Notice of Resolutions of the Annual General Meeting 2024

6.40 Mar 21, 2024: World’s first high-resolution brain developed by 3D printer

6.41 Mar 18, 2024: Siemens Healthineers Intends to Close Fast Track Diagnostics

6.42 Mar 05, 2024: Ariceum Therapeutics Announces Opening of New State-Of-The-Art Laboratory in Berlin Providing Infrastructure for Radiopharmaceutical Development Activities

6.43 Feb 26, 2024: Virtua Health Installs Innovative GE Healthcare Systems to Advance Cardiac Imaging in Southern New Jersey

6.44 Feb 20, 2024: Philips Delivers Strong ESG Performance in 2023

6.45 Feb 15, 2024: Philips Recalls Brightview Imaging Systems Due to the Detector Unexpectedly Falling

6.46 Feb 14, 2024: GE HealthCare Management to Present at Upcoming Investor Conferences

6.47 Feb 13, 2024: Siemens Announces a 22% Increase in Revenue at 14% Pbt (As A % Of Revenue) In Q1 Fy 2024 Results

6.48 Feb 09, 2024: RSNA: Novel Technique has Potential to Transform Breast Cancer Detection

6.49 Feb 08, 2024: Siemens Announces Successful Start to Fiscal 2024

6.50 Feb 01, 2024: United Imaging Announces Numerous Collaborative Relationships in the Middle East at Arab Health 2024

6.51 Jan 30, 2024: Prepaire Labs Signs MOU with United Imaging Healthcare for uExplorer Total Body PET CT Scanner at Arab Health Expo 2024

6.52 Jan 29, 2024: Siemens Medical Solutions USA Receives FDA 510(k) Clearance for Biograph VK10

6.53 Jan 18, 2024: GE HealthCare to Announce Fourth Quarter and Full Year 2023 Results on February 6, 2024

6.54 Jan 09, 2024: Lantheus Expands Radiopharmaceutical Oncology Pipeline via Strategic Agreements with Perspective Therapeutics

6.55 Jan 03, 2024: Case Western Reserve researchers land $1.1M National Science Foundation grant to advance safer, faster and less expensive medical-imaging technology

6.56 Dec 20, 2023: IBA Celebrates a New Milestone With the Sale of the 100th Cyclone KIUBE cyclotron

6.57 Dec 19, 2023: New PET Tracer Noninvasively Identifies Cancer Gene Mutation, Allows for More Precise Diagnosis and Therapy

6.58 Dec 12, 2023: MyCardiologist Revolutionizes Heart Health Assessment & Cardiac Event Reduction with Cutting-Edge Cardiac PET Imaging

6.59 Nov 27, 2023: Siemens Appoints Hakan Ozdemir as CEO of Smart Infrastructure in the Middle East

6.60 Nov 22, 2023: Siemens Healthineers Announces FDA Clearance of Biograph Vision.X PET/CT Scanner

6.61 Nov 22, 2023: Oxford Instruments Brings Hill & Smith CFO Hannah Nichols to Board

6.62 Nov 22, 2023: Oxford Instruments Names Hill & Smith CFO to Its Board

6.63 Nov 22, 2023: Oxford Instruments Announces Appointment of Independent Non-Executive Director

6.64 Nov 22, 2023: PET Positivity After Two Cycles of ABVD Is Associated with a Worse Outcome in Localised Hodgkin Lymphoma Although Intensification with BEACOPPesc Is Safe

6.65 Nov 20, 2023: Concord Medical Schedules 2023 Annual Meeting of Shareholders

6.66 Nov 14, 2023: Oxford Instruments Reports Interim Results for the Six Months to 30 September 2023

6.67 Nov 13, 2023: Alzheimer’s Association Applauds CMS Decision to Cover PET Imaging for Alzheimer’s Disease Diagnosis

6.68 Nov 09, 2023: Bone Scans Overstage Prostate Cancer at Initial Staging Compared with PSMA PET

6.69 Nov 08, 2023: Star Equity Holdings Announces 2023 Third Quarter Financial Results

6.70 Oct 26, 2023: Shanghai United Imaging Healthcare Receives Additional 510(K) Clearance For uMI Panorama

6.71 Oct 24, 2023: Cinven Acquires Majority Stake in Synlab AG

7 Appendix

7.1 Methodology

7.2 About GlobalData

7.3 Contact Us

7.4 Disclaimer

Table

Nuclear Imaging Equipment – Pipeline Products by Stage of Development

Nuclear Imaging Equipment – Pipeline Products by Segment

Nuclear Imaging Equipment – Pipeline Products by Territory

Nuclear Imaging Equipment – Pipeline Products by Regulatory Path

Nuclear Imaging Equipment – Pipeline Products by Estimated Approval Date

Nuclear Imaging Equipment – Ongoing Clinical Trials

Nuclear Imaging Equipment Companies – Pipeline Products by Stage of Development

Nuclear Imaging Equipment – Pipeline Products by Stage of Development

Brain Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview

CerePET – Product Status

CerePET – Product Description

FREEMotion – Product Status

FREEMotion – Product Description

Canon Medical Systems USA Inc Pipeline Products & Ongoing Clinical Trials Overview

Next Generation PET Detector – Product Status

Next Generation PET Detector – Product Description

Cubresa Inc Pipeline Products & Ongoing Clinical Trials Overview

BrainPET – Product Status

BrainPET – Product Description

ELECTRON Ltd. Pipeline Products & Ongoing Clinical Trials Overview

Complex Isotope Diagnostics Device – Product Status

Complex Isotope Diagnostics Device – Product Description

Emory University Pipeline Products & Ongoing Clinical Trials Overview

PET/CT Total Body Scan – Product Status

PET/CT Total Body Scan – Product Description

Endocyte Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

EC0652 – Prostate Cancer – Product Status

EC0652 – Prostate Cancer – Product Description

EXINI Diagnostics AB Pipeline Products & Ongoing Clinical Trials Overview

EXINI PET – Product Status

EXINI PET – Product Description

FMI Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview

ScintiStar Neuro 100 PET/CT/SPECT – Product Status

ScintiStar Neuro 100 PET/CT/SPECT – Product Description

ScintiStar Neuro 200 PET/CT/SPECT – Product Status

ScintiStar Neuro 200 PET/CT/SPECT – Product Description

General De Equipment for Medical Imaging SA Pipeline Products & Ongoing Clinical Trials Overview

CareMiBrain – Product Status

CareMiBrain – Product Description

PET System – Brain – Product Status

PET System – Brain – Product Description

Sentinella New Version – Product Status

Sentinella New Version – Product Description

General Electric Global Research Center Pipeline Products & Ongoing Clinical Trials Overview

Smart Cardiac CT Scanner – Product Status

Smart Cardiac CT Scanner – Product Description

Jagiellonian University Pipeline Products & Ongoing Clinical Trials Overview

Jagiellonian-PET TOMOGRAPHY – Product Status

Jagiellonian-PET TOMOGRAPHY – Product Description

Jagiellonian University – Ongoing Clinical Trials Overview

Jagiellonian-PET TOMOGRAPHY – Clinical Use of a J-PET Scanner Prototype Made of Plastic Scintilators

King’s College London Pipeline Products & Ongoing Clinical Trials Overview

18F-Labelled Molecular Probe – Product Status

18F-Labelled Molecular Probe – Product Description

Massachusetts General Hospital Pipeline Products & Ongoing Clinical Trials Overview

SPECT System – Product Status

SPECT System – Product Description

Memorial Sloan Kettering Cancer Center Pipeline Products & Ongoing Clinical Trials Overview

Micro-NMR System – Product Status

Micro-NMR System – Product Description

Molecular Dynamics Pipeline Products & Ongoing Clinical Trials Overview

Valiance X12 – Product Status

Valiance X12 – Product Description

Molecular Dynamics – Ongoing Clinical Trials Overview

Valiance X12 – Molecular Dynamics’ Innovative Whole-body CZT Digital SPECT/CT Trial

MultiFunctional Imaging LLC Pipeline Products & Ongoing Clinical Trials Overview

Dual-Tracer PET Device – Product Status

Dual-Tracer PET Device – Product Description

Nalu Scientific LLC Pipeline Products & Ongoing Clinical Trials Overview

SyMPET – Product Status

SyMPET – Product Description

Navidea Biopharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview

Lymphoseek – Product Status

Lymphoseek – Product Description

Navidea Biopharmaceuticals Inc – Ongoing Clinical Trials Overview

Lymphoseek – A Phase 1, Open-label Study to Investigate the Dosimetry of Tc-99m-Tilmanocept Following a Single Intravenous Dose Administration in Women and Men Suspected of Diabetic Nephropathy

Lymphoseek – Evaluation of Tc99m Tilmanocept Imaging for the Early Prediction of Anti-TNFa Therapy Response in Patients with Moderate to Severe Active Rheumatoid Arthritis (RA)

Neusoft Medical Systems Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

NeuWise PET/CT – Product Status

NeuWise PET/CT – Product Description

Noras MRI products GmbH Pipeline Products & Ongoing Clinical Trials Overview

PET-RF Insert – Product Status

PET-RF Insert – Product Description

Petcoil Inc Pipeline Products & Ongoing Clinical Trials Overview

PETcoil System – Product Status

PETcoil System – Product Description

Philips Healthcare Informatics Inc Pipeline Products & Ongoing Clinical Trials Overview

Additional PET Scan – Product Status

Additional PET Scan – Product Description

AFOV PET Scanner – Product Status

AFOV PET Scanner – Product Description

PET/CT Scanner – Myocardial Perfusion Assessment – Product Status

PET/CT Scanner – Myocardial Perfusion Assessment – Product Description

Positron Corporation Pipeline Products & Ongoing Clinical Trials Overview

Affinity PET-CT 4D – Product Status

Affinity PET-CT 4D – Product Description

Pulmoscience Inc Pipeline Products & Ongoing Clinical Trials Overview

PulmoBind – Product Status

PulmoBind – Product Description

QUIBIM SL Pipeline Products & Ongoing Clinical Trials Overview

Total-Body PET/CT Scanner – Product Status

Total-Body PET/CT Scanner – Product Description

Radialis Medical Inc Pipeline Products & Ongoing Clinical Trials Overview

Radialis PET Camera – Product Status

Radialis PET Camera – Product Description

Ruhr-University Bochum Pipeline Products & Ongoing Clinical Trials Overview

Precision Oncology Tool – Product Status

Precision Oncology Tool – Product Description

Senotrac Biotechnology LLC Pipeline Products & Ongoing Clinical Trials Overview

Brain Senescence Detection PET Probe – Product Status

Brain Senescence Detection PET Probe – Product Description

Shanghai United Imaging Healthcare Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

Neuro PET/CT – Product Status

Neuro PET/CT – Product Description

NeuroeXplorer – Product Status

NeuroeXplorer – Product Description

uPET-MR – Product Status

uPET-MR – Product Description

Shanghai United Imaging Intelligent Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

uMI Panorama GS – Product Status

uMI Panorama GS – Product Description

Siemens Healthineers AG Pipeline Products & Ongoing Clinical Trials Overview

4D Flow MRI Software – Product Status

4D Flow MRI Software – Product Description

Biograph mMR With Syngo MR E11 – Product Status

Biograph mMR With Syngo MR E11 – Product Description

Biograph Vision PET/CT System With QualityGuard – Product Status

Biograph Vision PET/CT System With QualityGuard – Product Description

xSPECT – Product Status

xSPECT – Product Description

xSPECT Bone – Product Status

xSPECT Bone – Product Description

xSPECT Quantification – Product Status

xSPECT Quantification – Product Description

Siemens Medical Solutions USA Inc Pipeline Products & Ongoing Clinical Trials Overview

Biograph Vision.X – Product Status

Biograph Vision.X – Product Description

Stanford University Pipeline Products & Ongoing Clinical Trials Overview

Brain-Dedicated PET System – Product Status

Brain-Dedicated PET System – Product Description

Breast-Dedicated PET System – Product Status

Breast-Dedicated PET System – Product Description

Dual Panel PET Scanner – Product Status

Dual Panel PET Scanner – Product Description

Dual-isotope Positron Emitting Tomography System – Product Status

Dual-isotope Positron Emitting Tomography System – Product Description

Next Generation TOF-PET System – Product Status

Next Generation TOF-PET System – Product Description

PET Sensitivity Enhancing System – Product Status

PET Sensitivity Enhancing System – Product Description

PET System – Product Status

PET System – Product Description

Stanford University – Ongoing Clinical Trials Overview

Breast-Dedicated PET System – Pilot Study of a Breast-dedicated PET Camera with 1 Millimeter Spatial Resolution

Brain-Dedicated PET System – Pilot Study for Simultaneous PET-MR Imaging of Covid-19 Associated Neurological Complications Using a Brain Dedicated PET Insert

Symetrica Security Ltd Pipeline Products & Ongoing Clinical Trials Overview

High Resolution Gamma Camera – Product Status

High Resolution Gamma Camera – Product Description

SynchroPET Pipeline Products & Ongoing Clinical Trials Overview

Arterial PET Scanner – Product Status

Arterial PET Scanner – Product Description

Breast PET-MRI – Product Status

Breast PET-MRI – Product Description

Terapet SA Pipeline Products & Ongoing Clinical Trials Overview

Nuclear Imaging Device – Product Status

Nuclear Imaging Device – Product Description

University of Arizona Pipeline Products & Ongoing Clinical Trials Overview

SPECT Imaging Tool – Product Status

SPECT Imaging Tool – Product Description

University of California Davis Pipeline Products & Ongoing Clinical Trials Overview

Excised Tissue Imager Device – Product Status

Excised Tissue Imager Device – Product Description

University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview

PSMA PET/CT Imaging Device – Product Status

PSMA PET/CT Imaging Device – Product Description

University of California Santa Cruz Pipeline Products & Ongoing Clinical Trials Overview

Head And Neck PET System – Product Status

Head And Neck PET System – Product Description

University of the Witwatersrand Pipeline Products & Ongoing Clinical Trials Overview

Coded Aperture Mask – Product Status

Coded Aperture Mask – Product Description

University of Washington Pipeline Products & Ongoing Clinical Trials Overview

DS-PS3 Positron Emission Tomography Detector – Product Status

DS-PS3 Positron Emission Tomography Detector – Product Description

High Resolution PET Detector – Product Status

High Resolution PET Detector – Product Description

West Virginia University Pipeline Products & Ongoing Clinical Trials Overview

PEM/PET-Breast Imager – Product Status

PEM/PET-Breast Imager – Product Description

Zecotek Photonics Inc Pipeline Products & Ongoing Clinical Trials Overview

New-Generation PET/MRI Scanning Device – Product Status

New-Generation PET/MRI Scanning Device – Product Description

ZumaTek, Inc. Pipeline Products & Ongoing Clinical Trials Overview

PET-CT Scanner – Product Status

PET-CT Scanner – Product Description

SPECT-CT Scanner – Product Status

SPECT-CT Scanner – Product Description

Glossary

Figures

Nuclear Imaging Equipment – Pipeline Products by Stage of Development

Nuclear Imaging Equipment – Pipeline Products by Segment

Nuclear Imaging Equipment – Pipeline Products by Territory

Nuclear Imaging Equipment – Pipeline Products by Regulatory Path

Nuclear Imaging Equipment – Pipeline Products by Estimated Approval Date

Nuclear Imaging Equipment – Ongoing Clinical Trials

Frequently asked questions

Nuclear Imaging Equipment Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies standard reports
Currency USD
$4,000

Can be used by individual purchaser only

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Download FREE Resources

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Sample Report

Nuclear Imaging Equipment Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Medical Devices
New
Global M&A Deals in H1 2026 - Top Themes by…
$495 | August 2026
Medical Devices
New
AI-designed Materials: Market Trends and Innovations
$995 | July 2026
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Nuclear Imaging Equipment Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies in real time.

  • Access a live Nuclear Imaging Equipment Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.